“I think 2026 is the year of fundamental, agentic transformation of the workflow.” Abridge co-founder and CTO Zack Lipton joins Bloomberg Intelligence analyst Jonathan Palmer to share how the company grew from a research-heavy idea into one of health care’s breakout AI leaders. Lipton breaks down the limits of point solutions, the complexity of evaluating generative AI in medicine, and why he sees the future not as a better digital scribe alone, but as a unified platform that can guide documentation, billing and care decisions in real time.

Virta Health’s Push to Reverse Metabolic Disease at Scale
48:52

Athenahealth's Strategic Reset, Push for Speed in Ambulatory Care
51:10

Inside Insilico Medicine’s AI Strategy and Lilly Breakthrough
59:53